ReviewAmerican journal of translational research2026
Multi-target modulation of traditional Chinese medicine based on the liver-gut axis: a new therapeutic strategy for NAFLD.
Review in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As one of the most common liver diseases, non-alcoholic fatty liver disease (NAFLD) has attracted widespread international attention given its rising incidence. The current mainstay of treatment for NAFLD is controlled diet with controlled exercise. Significantly, the development of NAFLD is proposed to be related to the liver-gut axis. The gut barrier function may be disrupted in the case of gut microbial dysbiosis, which may increase the entry of bacteria, lipopolysaccharides and endotoxins into the liver, causing an inflammatory response, increasing the load on the liver, and triggering lipid deposition, thereby advancing the progression of NAFLD. Simultaneously, liver injury can further alter intestinal permeability, inducing systemic inflammatory response, creating a vicious cycle that may subsequently exacerbate the development of NAFLD. Accordingly, the present review focused on the exploration of the relationship between the liver-gut axis and NAFLD, dissection of the biological mechanism of NAFLD induced by liver-gut axis dysfunction, and comprehensive elucidation of the research progress of Chinese medicine on the regulation of the liver-gut axis for treating NAFLD. It is expected that these findings may provide fresh and insightful evidence for the development of suitable preventive and therapeutic strategies of NAFLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.